课题基金 / 基金详情

Identification and regulation of factors related to progression of renal

Identification and regulation of factors related to progression of renal
肾病进展相关因素的识别和调控
批准号:
15390268
负责人:
SHIMIZU Fujio
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

SHIMIZU Fujio的其他基金

相关文献

中文摘要
翻译
主要研究结果如下:(1)基于前期研究发现足细胞损伤可使系膜损伤引起的可逆损伤转变为不可逆损伤,通过同时注射抗裂膜单克隆抗体(5-1-6)和抗y-1单克隆抗体(1-223),建立了大鼠进行性肾脏病变的不可逆模型。(2)肾小球内fractalkine表达的增加和肾小球内CX3CR1(fractalkine受体)阳性细胞浸润的增加与肾脏病变的进展密切相关。(3)针对cd4阳性细胞或Th1细胞因子或FK506 (Th1细胞因子阻滞剂)以及FTY720、MMF、螺内酯和ACE抑制剂的抗体可抑制肾脏病变的进展。(4)胶原酶活性降低是系膜基质增加的良好标志。(5)在mRNA水平上抑制tgf - β的表达可抑制系膜基质的增加。(6)中药、GTW可抑制Thy-1型肾炎患者尿蛋白、肾小球系膜基质增加及MCP-2、IL-2表达。(7)早期干预低蛋白饮食可延缓肾脏疾病的进展。
英文摘要
Summarized main results are : (1)A new irreversible model for progressive renal lesions has been established in rats by injecting simultaneously the anti-slit diaphragm monoclonal antibody (5-1-6) and anti-Thy-1 monoclonal antibody (1-22-3), based on our previous finding that podocyte injury could change the reversible injury derived from the mesangial injury to the irreversible one. (2)The increased intraglomerular expression of fractalkine and the increased intraglomerular infiltration of CX3CR1(receptor to fractalkine)-positive cells were intimately related to the progression of the renal lesions. (3)Antibodies against CD4-positive cells or Th1 cytokines or FK506 (blocker of Th1 cytokines as well as FTY720,MMF, spironolactone and ACE inhibitors suppressed the progression of renal lesions. (4)The decrease in the collagenase activity was a good marker for the increase of mesangial matrix. (5)The suppression of the expression of TGF-beta at mRNA level resulted in the suppression of the increase of mesangial matrix. (6)Traditional Chinese medicine, GTW could suppress the amount of urinary protein, mesangial matrix increase and the expression of MCP-2 and IL-2 expression in Thy-1 nephritis. (7)The eartly intervention with low protein diet could delay the progression of renal diseases.
期刊论文(103)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/sj.gt.3302480
发表时间: 2005-06-01
期刊: GENE THERAPY
影响因子: 5.1
作者: [Takabatake, Y, Isaka, Y, Imai, E]
通讯作者: Imai, E
Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in Experimental glomerulonephrities.
肾内注射骨髓来源的血管生成细胞可减少实验性肾小球肾中的内皮损伤和系膜细胞活化。
DOI: --
发表时间: 2005
期刊: Journal of the American Society of Nephrology 16
影响因子: --
作者: [Uchimura H.]
通讯作者: Uchimura H.
Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
单克隆抗体 1-22-3 在未肾切除大鼠中诱导肾小球肾炎,作为进行性肾衰竭模型。
DOI: --
发表时间: 2005
期刊: Nephrology Dialysis Transplantation 20
影响因子: --
作者: [Satoh J, et al., Harita Y., Satoh J. et al., Tomita M.]
通讯作者: Tomita M.
オーバービュー 腎疾患の実験医学
肾脏疾病实验医学概述
DOI: --
发表时间: 2004
期刊: 現代医療社 36
影响因子: --
作者: [Asai M, Monkawa T, Marumo T, Fukuda S, Tsuji M, Yoshino J, Kawachi H, Shimizu F, Hayashi M, Saruta T., Ma Ji., Ono T., Peters H., Ikezumi Y., Tomita M., 清水不二雄]
通讯作者: 清水不二雄
共 60 条
    Relaxation-less control of atomic motion and its applications to atom-optics
    • 批准号:
      22540408
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Analysis on the mechanism of proteinuria induced by glomerular epithelial cell lesions
    • 批准号:
      13470210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.71万
    • 财政年份:
      2001
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Physics and Applications of Laser Cooling (The Blanket Group)
    • 批准号:
      11216101
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $16.26万
    • 财政年份:
      1999
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Atom Optics (Technical Application of Laser Cooling)
    • 批准号:
      11216202
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $90.69万
    • 财政年份:
      1999
    • 负责人:
      SHIMIZU Fujio
    • 依托单位: